In vivo factors influencing tumour M2-pyruvate kinase level in human pancreatic cancer cell lines

被引:13
|
作者
Kumar, Yogesh [1 ]
Mazurek, Sybille [2 ,3 ]
Yang, Shiyu [1 ]
Failing, Klaus [4 ]
Winslet, Marc [1 ]
Fuller, Barry [1 ]
Davidson, Brian R. [1 ]
机构
[1] UCL, Royal Free & Univ Coll Med Sch, Univ Dept Surg, London NW3 2QG, England
[2] Univ Giessen, Fac Vet, Inst Biochem & Endocrinol, D-35392 Giessen, Germany
[3] ScheBo Biotech AG, D-35394 Giessen, Germany
[4] Univ Giessen, Fac Vet, Unit Biomath, D-35392 Giessen, Germany
关键词
pyruvate kinase M2; Tumour M2-PK; Tumour microenvironment; Pancreatic cancer; PYRUVATE-KINASE; MARKER; CARCINOMA; APOPTOSIS; GLUCOSE; M2; GLYCOLYSIS; METABOLISM; EXPRESSION; DIAGNOSIS;
D O I
10.1007/s13277-009-0010-3
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
In tumour cells, the tetramer/dimer ratio of the pyruvate kinase isoenzyme type M2 (M2-PK) determines whether glucose carbons are degraded to lactate with production of energy (tetrameric form) or are channelled into synthetic processes (dimeric form). The influence of different tumour microenvironment conditions on the tetramer/dimer ratio of M2-PK and cell doublings were investigated in a non-metastatic and metastatic pancreatic cancer cell line. The metastatic Colo357 cells contained about fourfold more M2-PK protein and about 3.5-fold more dimeric M2-PK than the non-metastatic Panc-1 cells. In Colo357 cells hypoxia, glucose starvation as well as acidification induced an increase of the dimeric form of M2-PK, whereas in Panc-1 cells no effect on M2-PK was observed. Under hypoxia in Colo357 cells, the dimerization and inactivation of M2-PK results in an inhibition of cell proliferation, whereas under glucose starvation and acidification the dimerization of M2-PK allowed further cell doublings. M2-PK expression and the quaternary structure of M2-PK are influenced by the tumour metastatic potential. The quaternary structure of M2-PK may be differently affected by hypoxia, glucose starvation and acidification with severe consequences on cell doublings.
引用
收藏
页码:69 / 77
页数:9
相关论文
共 50 条
  • [31] Overexpression of the M2 isoform of pyruvate kinase is an adverse prognostic factor for signet ring cell gastric cancer
    Lim, Jae Yun
    Yoon, Sun Och
    Seol, So Young
    Hong, Soon Won
    Kim, Jong Won
    Choi, Seung Ho
    Cho, Jae Yong
    WORLD JOURNAL OF GASTROENTEROLOGY, 2012, 18 (30) : 4037 - 4043
  • [32] Tumor M2-Pyruvate Kinase, Matrix Carbonic Anhydrase IX, and Metalloproteinase 9 - Novel Prognostic Markers of Renal Cell Carcinoma
    Amoev, Z., V
    Alyasova, A., V
    Gorshkova, T. N.
    Samsonova, E., I
    Strokina, E., V
    Kontorshchikova, K. N.
    SOVREMENNYE TEHNOLOGII V MEDICINE, 2020, 12 (02) : 43 - 47
  • [33] Methionine oxidation activates pyruvate kinase M2 to promote pancreatic cancer metastasis
    He, Dan
    Feng, Huijin
    Sundberg, Belen
    Yang, Jiaxing
    Powers, Justin
    Christian, Alec H.
    Wilkinson, John E.
    Monnin, Cian
    Avizonis, Daina
    Thomas, Craig J.
    Friedman, Richard A.
    Kluger, Michael D.
    Hollingsworth, Michael A.
    Grandgenett, Paul M.
    Klute, Kelsey A.
    Toste, F. Dean
    Chang, Christopher J.
    Chio, Iok In Christine
    MOLECULAR CELL, 2022, 82 (16) : 3045 - +
  • [34] Diagnostic accuracy of tumor M2-pyruvate kinase (tM2-PK) as a non-invasive biomarker in colorectal cancer: A systematic review and meta-analysis
    Aalami, Amir Hossein
    Shahriari, Ali
    Mazaheri, Mohammad
    Aalami, Farnoosh
    Amirabadi, Amir
    Sahebkar, Amirhossein
    CLINICAL BIOCHEMISTRY, 2023, 120
  • [35] The pyruvate kinase isoenzyme M2 (Tu M2-PK) as a tumour marker for renal cell carcinoma
    Weinberger, R.
    Appel, B.
    Stein, A.
    Metz, Y.
    Neheman, A.
    Barak, M.
    EUROPEAN JOURNAL OF CANCER CARE, 2007, 16 (04) : 333 - 337
  • [36] Pyruvate kinase M2 is highly correlated with the differentiation and the prognosis of esophageal squamous cell cancer
    Zhan, C.
    Shi, Y.
    Lu, C.
    Wang, Q.
    DISEASES OF THE ESOPHAGUS, 2013, 26 (07) : 746 - 753
  • [37] Masitinib Combined with Standard Gemcitabine Chemotherapy: In Vitro and In Vivo Studies in Human Pancreatic Tumour Cell Lines and Ectopic Mouse Model
    Humbert, Martine
    Casteran, Nathalie
    Letard, Sebastien
    Hanssens, Katia
    Iovanna, Juan
    Finetti, Pascal
    Bertucci, Francois
    Bader, Thomas
    Mansfield, Colin D.
    Moussy, Alain
    Hermine, Olivier
    Dubreuil, Patrice
    PLOS ONE, 2010, 5 (03):
  • [38] Comparison of Tumour-Specific Phenotypes in Human Primary and Expandable Pancreatic Cancer Cell Lines
    Guo, Feng
    Kan, Kejia
    Rueckert, Felix
    Rueckert, Wolfgang
    Li, Lin
    Eberhard, Johannes
    May, Tobias
    Sticht, Carsten
    Dirks, Wilhelm G.
    Reissfelder, Christoph
    Pallavi, Prama
    Keese, Michael
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2023, 24 (17)
  • [39] Tumor marker M2-pyruvate-kinase in differential diagnosis of chronic pancreatitis and pancreatic cancer
    Novotny, Ivo
    Dite, Petr
    Daskych, Milan
    Zakova, Anna
    Trna, Jan
    Novotna, H.
    Nechutova, H.
    HEPATO-GASTROENTEROLOGY, 2008, 55 (85) : 1475 - 1477
  • [40] Pyruvate Kinase M2 and Lactate Dehydrogenase A Are Overexpressed in Pancreatic Cancer and Correlate with Poor Outcome
    Mohammad, Goran Hamid
    Damink, S. W. M. Olde
    Malago, Massimo
    Dhar, Dipok Kumar
    Pereira, Stephen P.
    PLOS ONE, 2016, 11 (03):